Gilead Sciences (GILD) Minority Interest (2009 - 2026)

Gilead Sciences (GILD) has reported Minority Interest for 18 consecutive years, with -$84.0 million the latest figure, recorded in Q1 2026.

• Minority Interest for Q1 2026 came in at -$84.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$84.0 million (changed 0.0% YoY), and the FY2025 annual result was -$84.0 million, changed 0.0% from the prior year.
• Minority Interest was -$84.0 million for Q1 2026 at Gilead Sciences, roughly flat from -$84.0 million in the prior quarter.
• Over five years, Minority Interest peaked at -$12.0 million in Q1 2022 and troughed at -$84.0 million in Q4 2023.
• Average Minority Interest over 5 years is -$66.0 million, with a median of -$84.0 million recorded in 2023.
• Year-over-year, Minority Interest slumped 2500.0% in 2022 and changed 0.0% in 2024.
• Over 5 years, Minority Interest stood at -$31.0 million in 2022, then slumped by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025, then changed by 0.0% to -$84.0 million in 2026.
• Per Business Quant data, the three most recent Minority Interest figures were -$84.0 million in Q1 2026, -$84.0 million in Q4 2025, and -$84.0 million in Q3 2025.